DesignMedix

DesignMedix, Inc. is a drug development company focused on overcoming drug resistance, one of the major challenges impacting human health and drug development today. The DesignMedix approach offers both a mechanism to overcome resistance, and the ability to develop an ongoing series of novel drugs. DesignMedix has designed and synthesized a library of novel candidate drugs called (revoquine or RCQ compounds) to combat several important infectious diseases. In the company's most advanced drug development program, lead compounds have been shown to overcome malaria drug resistance in human red blood cells in vitro, and to provide a cure in animal models. Work on overcoming drug resistance in other diseases is ongoing

Products

VentureMash Items Related to this Venture

Ratings

http://www.designmedix.com/

Region

Portland

Location

See map: Google Maps